Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
92 hedge funds and large institutions have $17.8M invested in Zomedica Corp. in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 12 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
26% more capital invested
Capital invested by funds: $14.1M → $17.8M (+$3.7M)
6% more funds holding
Funds holding: 87 → 92 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$211K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$143K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$74K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ProShare Advisors
Bethesda,
Maryland
|
-$72.8K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$19.1K |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$9.02K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$6.14K |
| 5 |
HF
HRT Financial
New York
|
-$5.86K |
ZOM Hedge Fund Activity: Q4 2023 in Review
92 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2023, worth a combined $17.8M — up 26% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ZOM positions and 12 closed out — a net gain of 5 holders — while 18 added to existing stakes and 9 trimmed.
The largest buyer was Connective Capital Management, opening a new position worth an estimated $211K. The largest seller was ProShare Advisors, cutting an estimated $72.8K.
- 92 institutional investors held Zomedica Corp. (ZOM) as of Q4 2023, up from 87 in Q3 2023.
- Funds reported $17.8M of Zomedica Corp. stock for Q4 2023, up 26% quarter-over-quarter.
- 17 funds opened new Zomedica Corp. positions in Q4 2023 and 12 closed out, a net change of +5 holders.
- The largest Zomedica Corp. buyer in Q4 2023 was Connective Capital Management, an estimated $211K added.
- The largest Zomedica Corp. seller in Q4 2023 was ProShare Advisors, an estimated $72.8K sold.
Based on aggregated 13F filings for Q4 2023.